Brief: Jubilant Life Sciences Says Unit Enters Strategic Partnership With Sofie Biosciences
Nov 4 (Reuters) - Jubilant Life Sciences Ltd JULS.NS :
* UNIT JUBILANT PHARMA ENTERED INTO STRATEGIC PARTNERSHIP
WITH
SOFIE BIOSCIENCES
* UNDER DEAL, CO TO BUY 25% STAKE IN SOFIE BIOSCIENCES FOR
$25
MILLION
Source text for Eikon: ID:nBSE1dYWx9
Further company coverage: JULS.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Jubilant Pharmova
See all newsBrief: Jubilant Pharmova Sept-Quarter Consol Net Profit 312 Million Rupees
Brief: Jubilant Pharmova Says Jubilant Therapeutics Announces Oral Presentation Of Preliminary Phase 1 Clinical Data For JBI-802
India New Issue-Jubilant Pharmova to issue 3-year bonds, bankers say
India's Jubilant Pharmova eyes $150 mln through rupee debt sale, bankers say
Brief: Jubilant Pharmova To Consider Raising Of Funds Through Issuance Of Non- Convertible Debentures